![Actualite financiere : Actualite bourse](/img/photos/photo//603377795_64.jpg)
EssilorLuxottica: UBS confirms buy recommendation
(CercleFinance.com) - UBS believes that a weak quarter is widely expected.
The analyst confirms his Buy recommendation and TP of E232 ahead of the group's Q2 publication. This target implies 15% upside potential for the Franco-Italian optics group's stock.
Q2 is likely to be weak, but the outlook for 2025 and beyond remains encouraging. Thus, any pullback could create a more attractive entry point, in our view, UBS says.
Accelerating sales growth, easing margin pressures and EssilorLuxottica's defensive nature make us more positive for H2 2024 and beyond, the broker summarises.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
The analyst confirms his Buy recommendation and TP of E232 ahead of the group's Q2 publication. This target implies 15% upside potential for the Franco-Italian optics group's stock.
Q2 is likely to be weak, but the outlook for 2025 and beyond remains encouraging. Thus, any pullback could create a more attractive entry point, in our view, UBS says.
Accelerating sales growth, easing margin pressures and EssilorLuxottica's defensive nature make us more positive for H2 2024 and beyond, the broker summarises.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.